Search Results

1 - 10 of 396 items :

  • "chronic kidney disease" x
Clear All
Chronic kidney disease – pediatric risk factors

REFERENCES 1. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee. Averting the legacy of kidney disease-focus on childhood. Kidney Int. 2016; 89: 512–8. 2. Kaspar CD1, Bholah R, Bunchman TE. A Review of Pediatric Chronic Kidney Disease. Blood Purif. 2016; 41: 211–7. 3. Hartiala O, Magnussen CG, Kajander S, Knuuti J, Ukkonen H, Saraste A, Rinta-Kiikka I, Kainulainen S, Kähönen M, Hutri-Kähönen N, Laitinen T, Lehtimäki T, Viikari JS, Hartiala J, Juonala M, Raitakari OT. Adolescence risk factors are predictive of

Open access
in PRILOZI
Chronic Kidney Disease-Mineral Bone Disorder in Diabetes Mellitus Patients

References Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 298(17): 2038-2047, 2007. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462.293 adults in Taiwan. Lancet 371(9631): 2173-2182, 2008. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296

Open access
Peripheral Arterial Disease and Chronic Kidney Disease

peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 2007; 18:629. 4. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol . 2005;16(2):489–495. 5. Eggers PW, Godhes D, Pugh J. Nontraumatic extremity amputations in the Medicare end-stage renal disease population. Kidney Int. 1999;56 (4):1524-33 6. Menon V. Gul A, Sarnak MJ. Cardiovascular risk factors

Open access
in PRILOZI
Interpretation of Erythropoietin and Haemoglobin Levels in Patients with Various Stages of Chronic Kidney Disease

. Erythropoietin. Cold Spring Harb Perspect Med 2013; 3: a011619. 5. Tojo Y, Sekine H, Hirano I, Pan X, Souma T, Tsujita T, et al. Hypoxia Signaling Cascade for Erythropoietin Pro - duction in Hepatocytes. Molecular and Cellular Biology 2015; 35(15): 2658-72. 6. Sopić M, Joksić J, Spasojević-Kalimanovska V, Bogavac- Stanojević N, Simić-Ogrizović S, Kravljača M, Jelić Ivanović Z. Downregulation of AdipoR1 is associated with increased circulating adiponectin levels in serbian chronic kidney disease patients. J Med Biochem 2016; 35: 436

Open access
Associations between thyroid dysfunction and chronic kidney disease

dysfunction. Acta Endocrinologica (Copenh) 126: 253-259, 1992. 8. Iglesias P, Diez JJ. Thyroid dysfunction and kidney disease. Eur J Endocrinol 160: 503-515, 2009. 9. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266, 2002. 10. Carrero JJ, Qureshi AR, Axelsson J et al. Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J

Open access
The Prognosis of Patients with Chronic Kidney Disease and Diabetes Mellitus

References 1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl. 1): S1-S266, 2002. 2. *** KDIGO 2012 Guideline for Evaluation and Management of CKD. Kidney Int Suppl 3: 19-62, 2013. Available at http://www.kidney-international.org 3. Groop PH, Thomas MC, Moran JL et al. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes. 2009;58:1651-1658. 4. Go AS, Chertow GM, Fan D

Open access
Heart Failure and Chronic Kidney Disease in Type 2 Diabetes

References 1. Damman K, Valente MA, Voors AA, et al. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J . 2014;35:455-469. 2. Löfman I, Szummer K, Hagerman I, et al. Prevalence and prognostic impact of kidney disease on heart failure patients. Open Heart . 2016;3:e000324. 3. Shiba N, Shimokawa H. Chronic kidney disease and heart failure — Bidirectional close link and common therapeutic goal. J Cardiol. 2011;57:8-17. 4. International Diabetes Federation. IDF

Open access
Screening for Chronic Kidney Disease in Adult Males in Vojvodina: A Cross-Sectional Study

References 1. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 1−136. 2. Paripović A, Stajić N, Putnik J, Bogdanović R. Chronic kidney disease during a 12-year period at tertiary health institution. Srp Arh Celok Lek 2012; 140: 313−20. 3. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes

Open access
Evolution Of Moderate Chronic Kidney Disease In The Elderly

References 1. LOCATELLI F, POZZONI P. Chronic kidney disease in the elderly: is it really a premise for overwhelming renal failure? Kidney Int 2006; 69 (12): 2155-2166. 2. MIMRAN A. Renal function and aging. Nephrologie 1990; 11 (5):275-8 3. ASTOR BC, MUNTNER P, LEVIN A, EUSTACE JA, CORESH J. Association of kidney function with anemia: the Third National Healt and Nutrition Examination Survey(1988-1994). Arch Intern Med 2002; 162:1401-1408 4. COZZOLINO M, GALLIENI M, BRANCACCIO D

Open access
Fibroblast Growth Factor-23: A Novel Biomarker for Cardiovascular Disease in Chronic Kidney Disease Patients

REFERENCES 1. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N. European Uremic Toxin Work Group. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20: 1048-1056. 2. Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17: 2034-2047. 3. Astor BC, Hallan SI, Miller ER 3rd, Yeung E, Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and allcause mortality in the US population

Open access
in PRILOZI